Developer docs
API playgroundTry for free, no card

Search company profiles

Sevibe Cells

Full company profile

uuid000pbtw

Namestring
Sevibe Cells
Legal namestring
SEVIBE CELLS S.L.
Websiteurl
sevibe.es
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Sevibe Cells is a Spanish private cord blood and tissue bank headquartered in Barcelona, founded in 2004 and operating as a subsidiary of the FamiCord Group since 2012. The company collects, processes, and cryopreserves hematopoietic stem cells from umbilical cord blood and cord tissue at two laboratories in Madrid (AABB-accredited) and Girona (UNE-EN ISO 9001 certified), serving expectant parents in Spain through a direct-to-consumer model supplemented by partnerships with more than 1,500 hospitals and clinics and several leading health insurers.

The company's core offering is a one-time biological capture service priced as an upfront collection-and-processing fee combined with recurring annual storage fees, generating a long-tail subscription-style revenue stream with high customer retention. Beyond cryopreservation, Sevibe Cells has expanded its value proposition upstream with streaming childbirth preparation courses and a digital pregnancy calendar, seeking to engage expectant families earlier in the decision journey. The Madrid facility holds AABB accreditation — a globally recognized cord blood banking standard — while both labs operate under ISO 9001 quality systems and GDPR-compliant data handling.

Commercial go-to-market relies on regional offices across multiple Spanish cities, direct digital marketing, on-site hospital relationships, and insurer partnerships that embed the service into benefits packages. As a member of the FamiCord Group — the largest cord blood bank in Europe — Sevibe Cells benefits from group-level procurement, R&D, and processing scale, while contributing to the parent's broader pan-European biobank. The category is mature and regulated, with competitive differentiation anchored on accreditation, brand trust, hospital footprint, and lifetime biological continuity rather than technological novelty.

Short descriptiontext

Sevibe Cells is a Spanish private cord blood and tissue bank serving expectant parents nationwide, with two processing laboratories in Madrid and Girona, AABB accreditation, and distribution via 1,500+ hospital partnerships and health insurer deals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCerdanyola del Vallès, Spain
HQ citystring
Cerdanyola del Vallès
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cord blood banking, stem cell preservation, umbilical cord blood, autologous stem cells, family stem cell banking
Industry2 codes
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Cord Blood Banking / Stem Cell Banking Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Umbilical Cord Blood Stem Cell Preservation
TypeSubscription Recurring
Description

Collection, processing, testing, and long-term cryopreservation of hematopoietic stem cells from umbilical cord blood for autologous (family) use. Service includes sample collection kit, laboratory processing, quality testing, and annual storage fees.

sevibe.es
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Sevibe Cells is an autologous umbilical cord blood and tissue stem cell bank that collects, processes, tests, and cryopreserves hematopoietic and mesenchymal stem cells at childbirth for potential future family medical use. The company operates two proprietary AABB-accredited processing laboratories in Spain (Madrid and Girona) and delivers the sample collection kits to partner hospitals where cord blood is harvested at birth. Beyond core stem cell banking, the company offers supporting pregnancy-education content and streaming childbirth preparation courses led by midwives.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • More than 1,000,000 stem cell samples stored globally through FamiCord Group
+1 more record
Product overview1 text field

Sevibe Cells operates as a family stem cell banking service within the FamiCord Group, offering umbilical cord blood and tissue stem cell collection, processing, and long-term cryopreservation. The core service is the conservation of stem cells for autologous (family) use. Additional services include online childbirth preparation courses and pregnancy education content through their blog. The company maintains two processing laboratories in Spain (Madrid and Girona) and is accredited by the AABB.

Product and service2 records
1Umbilical Cord Blood Stem Cell Preservation
CategoryCord Blood Banking
Description

End-to-end service for expectant families in Spain covering collection kit delivery, harvest of umbilical cord blood at partner hospitals, laboratory processing and testing, and long-term cryopreservation of hematopoietic stem cells for autologous (family) future medical use. Service includes ongoing annual storage.

2Umbilical Cord Tissue Stem Cell Preservation
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Sevibe Cells is a subsidiary of FamiCord Group, the largest cord blood banking group in Europe and #3 worldwide. The partnership provides Sevibe with access to FamiCord's network of 14 laboratories worldwide, 1,500+ hospital partnerships, 20+ years of experience, and over 1,000,000 stored samples. FamiCord operates as the parent company providing shared infrastructure, expertise, and brand credibility across European markets including Albania, Germany, Bosnia, Bulgaria, Croatia, Cyprus, Denmark, Slovakia, Slovenia, Spain, Estonia, UK, Hungary, Italy, Kosovo, Latvia, Lithuania, Luxembourg, Macedonia, Montenegro, Poland, Portugal, Czech Republic, Romania, Serbia, Sweden, Switzerland, Turkey, Hong Kong, Kuwait, Lebanon, UAE, and South Africa.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-based cord blood bank part of FamiCord Group. Provides autologous cord blood and tissue storage to expectant parents; same business model and parent infrastructure as Sevibe but serving a different geography.

TypeBroad incumbent
Description

US private cord blood bank owned by Revvity (formerly PerkinElmer). Comparable autologous cord blood banking service and recurring storage model; larger, broader-portfolio incumbent operating in the US market.

TypeDirect peer
Description

Portuguese cord blood bank also under FamiCord Group. Operates the same autologous cord blood storage model with hospital collection network, AABB-aligned processing, and direct-to-consumer marketing — most directly comparable sibling to Sevibe in Iberia.

TypeRegional player
Description

UK-based private cord blood and tissue bank with European operations. Offers autologous and family banking comparable to Sevibe's core service, but with primary geographic focus on the UK rather than Iberia.

TypeBroad incumbent
Description

US-listed pioneer of private cord blood banking with a global installed base and multi-decade storage revenue stream. Serves a similar autologous-use value proposition but at much greater scale and as an established public incumbent.

TypeRegional player
Description

UK-headquartered private stem cell and cord blood bank with multi-country presence in Europe. Comparable autologous and family-banking service offering; serves overlapping European customers but is headquartered in the UK rather than Spain.

7Sorgente Vita
TypeDirect peer
Description

Italian FamiCord subsidiary operating autologous cord blood banking with similar hospital collection, processing and DTC marketing; another in-group direct comparable to Sevibe.

TypeDirect peer
Description

Poland's leading cord blood bank and another FamiCord Group subsidiary. Same autologous preservation service, hospital collection footprint, and multi-channel DTC acquisition; comparable scale and business model.

TypeDirect peer
Description

Swedish/Danish cord blood bank under FamiCord Group. Offers the same autologous stem cell storage service and hospital collection model in the Nordic market; closest direct sister to Sevibe in Northern Europe.

TypeDirect peer
Description

German autologous cord blood bank under FamiCord Group. Directly comparable service offering and operating model, focused on the DACH market; another sister entity to Sevibe.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sevibe Cells

Cord Blood Banking / Stem Cell Banking Servicessevibe.es

Sevibe Cells is a Spanish private cord blood and tissue bank serving expectant parents nationwide, with two processing laboratories in Madrid and Girona, AABB accreditation, and distribution via 1,500+ hospital partnerships and health insurer deals.

What Sevibe Cells does

Sevibe Cells is a Spanish private cord blood and tissue bank headquartered in Barcelona, founded in 2004 and operating as a subsidiary of the FamiCord Group since 2012. The company collects, processes, and cryopreserves hematopoietic stem cells from umbilical cord blood and cord tissue at two laboratories in Madrid (AABB-accredited) and Girona (UNE-EN ISO 9001 certified), serving expectant parents in Spain through a direct-to-consumer model supplemented by partnerships with more than 1,500 hospitals and clinics and several leading health insurers.

The company's core offering is a one-time biological capture service priced as an upfront collection-and-processing fee combined with recurring annual storage fees, generating a long-tail subscription-style revenue stream with high customer retention. Beyond cryopreservation, Sevibe Cells has expanded its value proposition upstream with streaming childbirth preparation courses and a digital pregnancy calendar, seeking to engage expectant families earlier in the decision journey. The Madrid facility holds AABB accreditation — a globally recognized cord blood banking standard — while both labs operate under ISO 9001 quality systems and GDPR-compliant data handling.

Commercial go-to-market relies on regional offices across multiple Spanish cities, direct digital marketing, on-site hospital relationships, and insurer partnerships that embed the service into benefits packages. As a member of the FamiCord Group — the largest cord blood bank in Europe — Sevibe Cells benefits from group-level procurement, R&D, and processing scale, while contributing to the parent's broader pan-European biobank. The category is mature and regulated, with competitive differentiation anchored on accreditation, brand trust, hospital footprint, and lifetime biological continuity rather than technological novelty.

Sevibe Cells firmographics

Firmographics
Name
Sevibe Cells
Legal name
SEVIBE CELLS S.L.
Website
https://sevibe.es
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
Sevibe Cells is a Spanish private cord blood and tissue bank serving expectant parents nationwide, with two processing laboratories in Madrid and Girona, AABB accreditation, and distribution via 1,500+ hospital partnerships and health insurer deals.
Ownership category
akta.pro rank

Sevibe Cells industry classification

Industry
Product category
Cord Blood Banking / Stem Cell Banking Services
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories

Keywords

  • Cord blood banking
  • Stem cell preservation
  • Umbilical cord blood
  • Autologous stem cells
  • Family stem cell banking

Where Sevibe Cells is headquartered

Location

Headquarters

HQ city
Cerdanyola del Vallès
HQ country
Spain
HQ region
Europe

Offices8 records

Markets served

Sevibe Cells business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Umbilical Cord Blood Stem Cell Preservation: Collection, processing, testing, and long-term cryopreservation of hematopoietic stem cells from umbilical cord blood for autologous (family) use. Service includes sample collection kit, laboratory processing, quality testing, and annual storage fees.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Sevibe Cells product offering

Product offering

Core offering

Sevibe Cells is an autologous umbilical cord blood and tissue stem cell bank that collects, processes, tests, and cryopreserves hematopoietic and mesenchymal stem cells at childbirth for potential future family medical use. The company operates two proprietary AABB-accredited processing laboratories in Spain (Madrid and Girona) and delivers the sample collection kits to partner hospitals where cord blood is harvested at birth. Beyond core stem cell banking, the company offers supporting pregnancy-education content and streaming childbirth preparation courses led by midwives.

Product overview

Sevibe Cells operates as a family stem cell banking service within the FamiCord Group, offering umbilical cord blood and tissue stem cell collection, processing, and long-term cryopreservation. The core service is the conservation of stem cells for autologous (family) use. Additional services include online childbirth preparation courses and pregnancy education content through their blog. The company maintains two processing laboratories in Spain (Madrid and Girona) and is accredited by the AABB.

Differentiator

Problem solved

Functional benefit

Products and services

  • Umbilical Cord Blood Stem Cell Preservation End-to-end service for expectant families in Spain covering collection kit delivery, harvest of umbilical cord blood at partner hospitals, laboratory processing and testing, and long-term cryopreservation of hematopoietic stem cells for autologous (family) future medical use. Service includes ongoing annual storage.
  • Umbilical Cord Tissue Stem Cell Preservation

Quantifiable outcome

  • More than 1,000,000 stem cell samples stored globally through FamiCord Group
  • +1 more outcomes

Companies that use Sevibe Cells

Customer profile

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Sevibe Cells technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Sevibe Cells partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • FamiCord GroupflagshipStrategic or Co-development PartnerSevibe Cells is a subsidiary of FamiCord Group, the largest cord blood banking group in Europe and #3 worldwide. The partnership provides Sevibe with access to FamiCord's network of 14 laboratories worldwide, 1,500+ hospital partnerships, 20+ years of experience, and over 1,000,000 stored samples. FamiCord operates as the parent company providing shared infrastructure, expertise, and brand credibility across European markets including Albania, Germany, Bosnia, Bulgaria, Croatia, Cyprus, Denmark, Slovakia, Slovenia, Spain, Estonia, UK, Hungary, Italy, Kosovo, Latvia, Lithuania, Luxembourg, Macedonia, Montenegro, Poland, Portugal, Czech Republic, Romania, Serbia, Sweden, Switzerland, Turkey, Hong Kong, Kuwait, Lebanon, UAE, and South Africa.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Sevibe Cells competitors and assessment

Company assessment

Direct peers

  • Smart Cells: UK-based cord blood bank part of FamiCord Group. Provides autologous cord blood and tissue storage to expectant parents; same business model and parent infrastructure as Sevibe but serving a different geography.
  • Crioestaminal: Portuguese cord blood bank also under FamiCord Group. Operates the same autologous cord blood storage model with hospital collection network, AABB-aligned processing, and direct-to-consumer marketing — most directly comparable sibling to Sevibe in Iberia.
  • Sorgente Vita: Italian FamiCord subsidiary operating autologous cord blood banking with similar hospital collection, processing and DTC marketing; another in-group direct comparable to Sevibe.
  • PBKM (Polski Bank Komórek Macierzystych): Poland's leading cord blood bank and another FamiCord Group subsidiary. Same autologous preservation service, hospital collection footprint, and multi-channel DTC acquisition; comparable scale and business model.
  • Cellaviva: Swedish/Danish cord blood bank under FamiCord Group. Offers the same autologous stem cell storage service and hospital collection model in the Nordic market; closest direct sister to Sevibe in Northern Europe.
  • Eticur: German autologous cord blood bank under FamiCord Group. Directly comparable service offering and operating model, focused on the DACH market; another sister entity to Sevibe.

Broad incumbents

  • ViaCord (Revvity): US private cord blood bank owned by Revvity (formerly PerkinElmer). Comparable autologous cord blood banking service and recurring storage model; larger, broader-portfolio incumbent operating in the US market.
  • Cryo-Cell International: US-listed pioneer of private cord blood banking with a global installed base and multi-decade storage revenue stream. Serves a similar autologous-use value proposition but at much greater scale and as an established public incumbent.

Regional players

  • Cells4Life: UK-based private cord blood and tissue bank with European operations. Offers autologous and family banking comparable to Sevibe's core service, but with primary geographic focus on the UK rather than Iberia.
  • Future Health Biobank: UK-headquartered private stem cell and cord blood bank with multi-country presence in Europe. Comparable autologous and family-banking service offering; serves overlapping European customers but is headquartered in the UK rather than Spain.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Sevibe Cells social profiles

Digital presence

Sevibe Cells compliance and trust

Trust signal

Compliance2 records

Sevibe Cells financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sevibe Cells leadership team

Management profile

Number of profiles

Profiles1 record

Sevibe Cells funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sevibe Cells M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sevibe Cells

What does Sevibe Cells do?

Sevibe Cells is an autologous umbilical cord blood and tissue stem cell bank that collects, processes, tests, and cryopreserves hematopoietic and mesenchymal stem cells at childbirth for potential future family medical use. The company operates two proprietary AABB-accredited processing laboratories in Spain (Madrid and Girona) and delivers the sample collection kits to partner hospitals where cord blood is harvested at birth. Beyond core stem cell banking, the company offers supporting pregnancy-education content and streaming childbirth preparation courses led by midwives.

Is Sevibe Cells a public or private company?

Sevibe Cells is a private company. It is classified as corporate owned and is currently operating.

When was Sevibe Cells founded?

Sevibe Cells was founded in 2004. It employs 11 to 50 people.

Where is Sevibe Cells based?

Sevibe Cells is headquartered in Cerdanyola del Vallès, Spain, in the Europe region.

How does Sevibe Cells make money?

One revenue line is on record: umbilical Cord Blood Stem Cell Preservation.

Who are Sevibe Cells's main competitors?

Direct peers on record are Smart Cells, Crioestaminal, Sorgente Vita, PBKM (Polski Bank Komórek Macierzystych), Cellaviva and Eticur. Broad incumbents are ViaCord (Revvity) and Cryo-Cell International. Regional players are Cells4Life and Future Health Biobank.

Does Sevibe Cells have an API?

No public API is recorded for Sevibe Cells.

What industry is Sevibe Cells in?

Sevibe Cells's product category is Cord Blood Banking / Stem Cell Banking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAFAMAH, Genetic & Prenatal Testing Laboratories. Its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales